Cargando…
P897: EVALUATION OF THE PROGNOSTIC IMPACT OF SECOND LINE ANTI-MYELOMA TREATMENTS ON POST- PROGRESSION OUTCOMES IN THE REAL-WORLD SETTING: THE GREEK MYELOMA STUDY GROUP EXPERIENCE.
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431163/ http://dx.doi.org/10.1097/01.HS9.0000970492.08047.86 |
| _version_ | 1785091136022380544 |
|---|---|
| author | Katodritou, Eirini Kastritis, Efstathios Dalampira, Dimitra Theodorakakou, Fotini Delimpasi, Sosana Spanoudakis, Emmanouil Ntanasis-Stathopoulos, Ioannis Papadopoulou, Theodosia Sevastoudi, Aggeliki Triantafyllou, Theodora Daiou, Aikaterini Labropoulou, Vasiliki Pouli, Anastasia Roussou, Maria Gavriatopoulou, Maria Verrou, Evgenia Dimopoulos, Meletios A. Terpos, Evangelos |
| author_facet | Katodritou, Eirini Kastritis, Efstathios Dalampira, Dimitra Theodorakakou, Fotini Delimpasi, Sosana Spanoudakis, Emmanouil Ntanasis-Stathopoulos, Ioannis Papadopoulou, Theodosia Sevastoudi, Aggeliki Triantafyllou, Theodora Daiou, Aikaterini Labropoulou, Vasiliki Pouli, Anastasia Roussou, Maria Gavriatopoulou, Maria Verrou, Evgenia Dimopoulos, Meletios A. Terpos, Evangelos |
| author_sort | Katodritou, Eirini |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10431163 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104311632023-08-17 P897: EVALUATION OF THE PROGNOSTIC IMPACT OF SECOND LINE ANTI-MYELOMA TREATMENTS ON POST- PROGRESSION OUTCOMES IN THE REAL-WORLD SETTING: THE GREEK MYELOMA STUDY GROUP EXPERIENCE. Katodritou, Eirini Kastritis, Efstathios Dalampira, Dimitra Theodorakakou, Fotini Delimpasi, Sosana Spanoudakis, Emmanouil Ntanasis-Stathopoulos, Ioannis Papadopoulou, Theodosia Sevastoudi, Aggeliki Triantafyllou, Theodora Daiou, Aikaterini Labropoulou, Vasiliki Pouli, Anastasia Roussou, Maria Gavriatopoulou, Maria Verrou, Evgenia Dimopoulos, Meletios A. Terpos, Evangelos Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431163/ http://dx.doi.org/10.1097/01.HS9.0000970492.08047.86 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Katodritou, Eirini Kastritis, Efstathios Dalampira, Dimitra Theodorakakou, Fotini Delimpasi, Sosana Spanoudakis, Emmanouil Ntanasis-Stathopoulos, Ioannis Papadopoulou, Theodosia Sevastoudi, Aggeliki Triantafyllou, Theodora Daiou, Aikaterini Labropoulou, Vasiliki Pouli, Anastasia Roussou, Maria Gavriatopoulou, Maria Verrou, Evgenia Dimopoulos, Meletios A. Terpos, Evangelos P897: EVALUATION OF THE PROGNOSTIC IMPACT OF SECOND LINE ANTI-MYELOMA TREATMENTS ON POST- PROGRESSION OUTCOMES IN THE REAL-WORLD SETTING: THE GREEK MYELOMA STUDY GROUP EXPERIENCE. |
| title | P897: EVALUATION OF THE PROGNOSTIC IMPACT OF SECOND LINE ANTI-MYELOMA TREATMENTS ON POST- PROGRESSION OUTCOMES IN THE REAL-WORLD SETTING: THE GREEK MYELOMA STUDY GROUP EXPERIENCE. |
| title_full | P897: EVALUATION OF THE PROGNOSTIC IMPACT OF SECOND LINE ANTI-MYELOMA TREATMENTS ON POST- PROGRESSION OUTCOMES IN THE REAL-WORLD SETTING: THE GREEK MYELOMA STUDY GROUP EXPERIENCE. |
| title_fullStr | P897: EVALUATION OF THE PROGNOSTIC IMPACT OF SECOND LINE ANTI-MYELOMA TREATMENTS ON POST- PROGRESSION OUTCOMES IN THE REAL-WORLD SETTING: THE GREEK MYELOMA STUDY GROUP EXPERIENCE. |
| title_full_unstemmed | P897: EVALUATION OF THE PROGNOSTIC IMPACT OF SECOND LINE ANTI-MYELOMA TREATMENTS ON POST- PROGRESSION OUTCOMES IN THE REAL-WORLD SETTING: THE GREEK MYELOMA STUDY GROUP EXPERIENCE. |
| title_short | P897: EVALUATION OF THE PROGNOSTIC IMPACT OF SECOND LINE ANTI-MYELOMA TREATMENTS ON POST- PROGRESSION OUTCOMES IN THE REAL-WORLD SETTING: THE GREEK MYELOMA STUDY GROUP EXPERIENCE. |
| title_sort | p897: evaluation of the prognostic impact of second line anti-myeloma treatments on post- progression outcomes in the real-world setting: the greek myeloma study group experience. |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431163/ http://dx.doi.org/10.1097/01.HS9.0000970492.08047.86 |
| work_keys_str_mv | AT katodritoueirini p897evaluationoftheprognosticimpactofsecondlineantimyelomatreatmentsonpostprogressionoutcomesintherealworldsettingthegreekmyelomastudygroupexperience AT kastritisefstathios p897evaluationoftheprognosticimpactofsecondlineantimyelomatreatmentsonpostprogressionoutcomesintherealworldsettingthegreekmyelomastudygroupexperience AT dalampiradimitra p897evaluationoftheprognosticimpactofsecondlineantimyelomatreatmentsonpostprogressionoutcomesintherealworldsettingthegreekmyelomastudygroupexperience AT theodorakakoufotini p897evaluationoftheprognosticimpactofsecondlineantimyelomatreatmentsonpostprogressionoutcomesintherealworldsettingthegreekmyelomastudygroupexperience AT delimpasisosana p897evaluationoftheprognosticimpactofsecondlineantimyelomatreatmentsonpostprogressionoutcomesintherealworldsettingthegreekmyelomastudygroupexperience AT spanoudakisemmanouil p897evaluationoftheprognosticimpactofsecondlineantimyelomatreatmentsonpostprogressionoutcomesintherealworldsettingthegreekmyelomastudygroupexperience AT ntanasisstathopoulosioannis p897evaluationoftheprognosticimpactofsecondlineantimyelomatreatmentsonpostprogressionoutcomesintherealworldsettingthegreekmyelomastudygroupexperience AT papadopouloutheodosia p897evaluationoftheprognosticimpactofsecondlineantimyelomatreatmentsonpostprogressionoutcomesintherealworldsettingthegreekmyelomastudygroupexperience AT sevastoudiaggeliki p897evaluationoftheprognosticimpactofsecondlineantimyelomatreatmentsonpostprogressionoutcomesintherealworldsettingthegreekmyelomastudygroupexperience AT triantafylloutheodora p897evaluationoftheprognosticimpactofsecondlineantimyelomatreatmentsonpostprogressionoutcomesintherealworldsettingthegreekmyelomastudygroupexperience AT daiouaikaterini p897evaluationoftheprognosticimpactofsecondlineantimyelomatreatmentsonpostprogressionoutcomesintherealworldsettingthegreekmyelomastudygroupexperience AT labropoulouvasiliki p897evaluationoftheprognosticimpactofsecondlineantimyelomatreatmentsonpostprogressionoutcomesintherealworldsettingthegreekmyelomastudygroupexperience AT poulianastasia p897evaluationoftheprognosticimpactofsecondlineantimyelomatreatmentsonpostprogressionoutcomesintherealworldsettingthegreekmyelomastudygroupexperience AT roussoumaria p897evaluationoftheprognosticimpactofsecondlineantimyelomatreatmentsonpostprogressionoutcomesintherealworldsettingthegreekmyelomastudygroupexperience AT gavriatopouloumaria p897evaluationoftheprognosticimpactofsecondlineantimyelomatreatmentsonpostprogressionoutcomesintherealworldsettingthegreekmyelomastudygroupexperience AT verrouevgenia p897evaluationoftheprognosticimpactofsecondlineantimyelomatreatmentsonpostprogressionoutcomesintherealworldsettingthegreekmyelomastudygroupexperience AT dimopoulosmeletiosa p897evaluationoftheprognosticimpactofsecondlineantimyelomatreatmentsonpostprogressionoutcomesintherealworldsettingthegreekmyelomastudygroupexperience AT terposevangelos p897evaluationoftheprognosticimpactofsecondlineantimyelomatreatmentsonpostprogressionoutcomesintherealworldsettingthegreekmyelomastudygroupexperience |